Adding Axona to Alzheimer's disease management may address a specific nutritional deficiency not addressed by FDA-approved Alzheimer's treatments.
We also want to provide you with support and keep you informed and up-to-date.
An unique opportunity to present your own work and data is not to be missed.
On the cultural front we are confident about making it a memorable one since Indian hospitality requires no proof.
Read Accera's response to the recent FDA warning letter.